The Company's Third Share Buyback This Year

Celltrion Healthcare announced on the 6th that it has decided to acquire treasury shares worth 25 billion KRW.


Celltrion Healthcare CI. [Image provided by Celltrion Healthcare]

Celltrion Healthcare CI. [Image provided by Celltrion Healthcare]

View original image

The treasury shares that Celltrion Healthcare decided to purchase this time total 380,000 shares, with an acquisition amount of approximately 25 billion KRW. The treasury shares will be acquired through on-market purchases from the 7th of this month until October 6th.


With this, Celltrion Healthcare has decided to repurchase treasury shares for the third time this year, following purchases in February and March. Upon completion of this purchase, the company will have acquired a total of 1,215,000 shares worth 75 billion KRW this year alone.


Last year, Celltrion Healthcare also acquired a total of 1,303,854 shares (85 billion KRW) in two rounds. Additionally, the company explained that it has continuously made efforts to return shareholder value, including deciding on simultaneous cash and stock dividends.


A representative of Celltrion Healthcare stated, "Despite the business competitiveness being further strengthened, we judged that the stock price level is still undervalued, leading to the decision for additional treasury share repurchases. We plan to continue doing our best to strengthen the company's competitiveness and will also maintain responsible management to enhance corporate and shareholder value."



Meanwhile, its affiliate Celltrion also announced an additional treasury share repurchase worth about 50 billion KRW the day before, having decided on treasury share acquisitions totaling approximately 200 billion KRW in four rounds this year.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing